American College of Cardiology
Avatar

MASTER DAPT: Dual Antiplatelet Therapy After PCI in Patients at High Bleeding Risk

By American College of Cardiology FEATURING Valentin Fuster, Dipti Itchhaporia, Michael Mack, Christine Albert, Julia Grapsa
February 15, 2022
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
28:11
Top Ten Topics in Clinical Cardiology 2021

Time to Retire Aspirin?

Feat. R. Mehran
15:40
ACC 2022 Conference Coverage

ACC 2022: Triple Therapy - When to Use and How Long

Feat. D. Kumbhani
11:26
Houston Methodist DeBakey Heart and Vascular Center

Aspirin for the Primary Prevention of Cardiovascular Disease: What C…

Feat. M. Miedema
21:51
Cedars Sinai

Treating Stenosis or Ischemia Does Not Improve Outcomes: Medical The…

Feat. W. Boden
07:10
American College of Cardiology

Ticagrelor with or without Aspirin in ACS after PCI (TICO)

Feat. P. Block, Y. Jang
11:07
Houston Methodist DeBakey Heart and Vascular Center

Aspirin & Primary Prevention: What Do the Guidelines Say?

Feat. M. Gulati
17:49
CHEST 2022 Coverage

Perioperative Management of Antithrombotic Therapy

Feat. J. Douketis
20:06
Canadian Collaborative Research Network

Stable CAD: ASA Alone, Prolonged DAPT or Low-Dose Rivaroxaban?

Feat. M. Sabatine
12:46
AHA 2022 Conference Coverage

AHA 2022 Debate: Should CABG Be Level IIB for Improving Survival Com…

Feat. F. Bakaeen
14:20
ARCH Advanced Revascularization Symposium

Highlights and Critiques of ACC/AHA/SCAI Revascularization Guidelines

Feat. D. A. Cox
14:31
ARCH Advanced Revascularization Symposium

Updates on Pharmacology in the Cath Lab

Feat. J. Goetz
25:26
The Texas Heart Institute

The Use of Coronary Artery Calcium Score to Determine Benefit of Asp…

Feat. E. Hernandez
15:13
Cardiometabolic Health Congress (CMHC)

Dual Pathway Inhibition in the Cardiometabolic Patient: How Effectiv…

Feat. D. Bhatt
37:35
Top Ten Topics in Clinical Cardiology 2022

Top 10 Coronary Interventional Trials of 2022

Feat. S. Sharma
16:34
AHA 2022 Conference Coverage

AHA 2022: Bivalirudin With a Post-PCI High-Dose Infusion versus Hepa…

Feat. G. W. Stone
13:36
Houston Methodist DeBakey Heart and Vascular Center

Plaque, Thrombosis and Bleeding Risk: Use of Antiplatelet Therapy

Feat. J. Ferreiro
16:04
The 8th Annual Western New England Acute Cardiology Conference

Antiplatelet Therapy After STEMI

Feat. R. Mehran
12:53
Scottsdale Interventional Forum 2018

What is the Optimal DAPT Duration?

Feat. R. Yeh
08:07
Houston Methodist DeBakey Heart and Vascular Center

Anti Platelet Therapy Clinical Case Discussion: Q&A with Dr. Nea…

Feat. N. Kleiman
17:19
1st Annual Heart of Prevention Symposium

Anti-platelets in Primary and Secondary Prevention

Feat. C. Kliger